Literature DB >> 9746124

Undertreatment of hypertension in a population-based study in The Netherlands.

O H Klungel1, A de Boer, A H Paes, J C Seidell, N J Nagelkerke, A Bakker.   

Abstract

OBJECTIVE: To estimate the level of undertreatment of hypertension in a population-based study by taking into account the co-existence of additional cardiovascular risk factors in untreated hypertensives, uncontrolled blood pressure among pharmacologically treated hypertensives and within-person variability in blood pressure and total cholesterol.
DESIGN: Cross-sectional.
SETTING: Two population-based surveys on cardiovascular disease risk factors conducted during 1987-1995 in The Netherlands. PARTICIPANTS: 56 026 men and women aged 20-59 years. MAIN OUTCOME MEASURES: Prevalence of hypertension, of treatment and of undertreatment of hypertension. Undertreated hypertensives were those who were treated pharmacologically, but whose blood pressure was still elevated and those who inappropriately received no medication for the treatment of hypertension.
RESULTS: During the past decade in The Netherlands, 30% of the hypertensive women and 47% of the hypertensive men aged 20-59 years were undertreated for hypertension. In both men and women treated pharmacologically, 42 and 29%, respectively, still had elevated blood pressure levels. Of those hypertensive men and women not treated pharmacologically, 53 and 34%, respectively, should have been treated when additional cardiovascular risk factors were taken into account Among those diagnosed but untreated for hypertension, 58 and 31% of the men and women, respectively, should have been treated pharmacologically.
CONCLUSION: A considerable proportion of hypertensives were undertreated for hypertension. To decrease the undertreatment of hypertension, it is necessary to obtain better control of blood pressure in patients already being treated, increase the detection of hypertension and improve adherence to the current guidelines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746124     DOI: 10.1097/00004872-199816090-00018

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands.

Authors:  O H Klungel; A de Boer; A H Paes; R M Herings; J C Seidell; A Bakker
Journal:  Pharm World Sci       Date:  1999-10

2.  The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs.

Authors:  Jarir Atthobari; Taco B M Monster; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

3.  The Nigerian antihypertensive adherence trial: a community-based randomized trial.

Authors:  Adebowale Adeyemo; Bamidele O Tayo; Amy Luke; Olugbenga Ogedegbe; Ramon Durazo-Arvizu; Richard S Cooper
Journal:  J Hypertens       Date:  2013-01       Impact factor: 4.844

4.  Knowledge and Practice of PHC Physicians toward the Detection and Management of Hypertension and Other CVD Risk Factors in Egypt.

Authors:  Mostafa A Abolfotouh; Laila A Soliman; Sameh M Abolfotouh; Mohamed Raafat
Journal:  Int J Hypertens       Date:  2011-08-11       Impact factor: 2.420

5.  Cost effectiveness of an adherence-improving programme in hypertensive patients.

Authors:  Danielle E M Brunenberg; Gwenn E C Wetzels; Patricia J Nelemans; Carmen D Dirksen; Johan L Severens; Henri E J H Stoffers; Jan S A G Schouten; Martin H Prins; Peter W de Leeuw; Manuela A Joore
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.